These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6143962)

  • 1. HTLV and haemophilia.
    Lee CA; Kernoff PB; Bofill M; Rizza CR; Downing RG
    Lancet; 1984 May; 1(8384):1028. PubMed ID: 6143962
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in prevalence of anti-HTLV-III in haemophiliacs.
    Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
    Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 7. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III, haemophilia, and blood transfusion.
    Bloom AL; Forbes CD; Rizza CR
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1901-2. PubMed ID: 2988692
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Felding P; Nilsson IM; Hansson BG; Biberfeld G
    Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
    [No Abstract]   [Full Text] [Related]  

  • 10. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 13. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
    Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
    Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state].
    Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F
    Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
    De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
    Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of immune defects in hemophilia with HTLV-III antibody titers.
    Daniel V; Opelz G; Schäfer A; Schimpf K; Wendler I; Hunsmann G
    Vox Sang; 1986; 51(1):35-9. PubMed ID: 2874661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
    Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I
    J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
    Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
    Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.
    Lynn TC; Hsieh RP; Lin KT; Shen MC; Chen DS; Wang CH; Liu CH; Wang JH; Lai MY; Liou MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):172-6. PubMed ID: 6096089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.